IN8Bio
IN8bio is a New York-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 11-50
Industries / Tags:
Detailed IN8Bio Information
Geographic Data
Address: 79 Madison Avenue
City: New York
State: NY
Zip: 10016
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$500k
Raised Total:$46M
Social
Metrics
1,931,463Website Global Rank
13,029Website Monthly Traffic
Twitter Followers
Description
IN8bio is a New York-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of cancer.
Contact Phone:
+16466006438
Contact Email:
IN8Bio went public on 7/30/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/30/2021
IPO Valuation:
$750M
Ticker Symbol:
INAB
IPO Price:
$40/share
Amount Raised:
$40M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2018 | Equity | $35M | 8/2022 | Post-IPO Equity | $10.8M | 8/2022 | Post-IPO Equity | $10.3M | 8/2022 | Post-IPO Equity | $500k | 1/2019 | Series A | 1 | $35M |
Bios Partners Bios Partners Bios Partners Bios Partners |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
